Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 2:50 pm Purchase | 13G | TRXADE HEALTH INC PAR $0.0 MEDS | ARMISTICE CAPITAL LLC | 65,502 4.99% | 65,502 (New Position) | View |
| 2023-02-14 1:05 pm Purchase | 13G | TRXADE HEALTH, INC. MEDS | ARMISTICE CAPITAL LLC | 977,103 9.99% | 977,103 (New Position) | View |
| 2022-10-19 4:30 pm Purchase | 13D | TRXADE HEALTH, INC. MEDS | AJJARAPU SURENDRA K | 2,288,824 24.5% | 71,100 (+3.21%) | View |
| 2022-10-19 4:30 pm Sale | 13D | TRXADE HEALTH, INC. MEDS | Patel Prashant | 2,092,371 22.4% | -4,504 (-0.21%) | View |
| 2020-06-30 5:00 pm Purchase | 13D | TRXADE HEALTH, INC. MEDS | Patel Prashant | 2,096,875 26% | 2,096,875 (New Position) | View |
| 2020-06-16 5:00 pm Sale | 13D | TRXADE HEALTH, INC. MEDS | AJJARAPU SURENDRA K | 2,217,724 28.8% | -200,572 (-8.29%) | View |
| 2020-04-21 5:21 pm Purchase | 13D | TRXADE HEALTH, INC. MEDS | AJJARAPU SURENDRA K | 2,418,296 31.4% | 2,418,296 (New Position) | View |
| 2019-10-07 6:29 pm Purchase | 13G | TRXADE HEALTH INC PAR $0.0 MEDS | R.S.N. LLC | 3,000,000 7.7% | 1,000,000 (+50.00%) | View |
| 2019-08-02 09:22 am Purchase | 13G | TRXADE HEALTH INC PAR $0.0 MEDS | R.S.N. LLC | 2,000,000 5.6% | 2,000,000 (New Position) | View |